Andere talen Telix Pharmaceuticals Limited

Aandelen

TLX

AU000000TLX2

Beurs gesloten - Australian S.E. Andere beurzen 08:10:11 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,24 ^AUD	+2,97%		+6,57%	+51,19%

01:51	Telix Pharmaceuticals rondt overname van QSAM Biosciences en geneesmiddel Samarium-153-DOTMP af	MT
30/04	TELIX PHARMACEUTICALS LIMITED : Bell Potter herziet opinie en gaat over naar Neutraal	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP	01:51
Telix to Showcase Extensive Urologic Pipeline at AUA Annual Meeting including Phase III ProstACT GLOBAL Study of TLX591	01/05
Telix - Notice of Annual General Meeting 2024	22/04
Q1 2024 Revenue and Business Update	17/04
Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024	17/04
Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024	17/04
Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1	17/04
Telix Pharmaceuticals Secures US FDA Fast-Track Designation for Brain Cancer Imaging Product	16/04
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation	16/04
Telix Pharmaceuticals Limited Announces FDA Fast Track Designation for TLX101-CDx	16/04
Telix Pharmaceuticals Limited schließt die Übernahme von ARTMS, Inc. ab.	11/04
Telix Pharmaceuticals Limited completa la adquisición de ARTMS Inc.	11/04
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.	11/04
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS	11/04
Telix Pharmaceuticals Limited completed the acquisition of ARTMS, INC.	11/04
Telix Pharmaceuticals Completes Acquisition of IsoTherapeutics Group	09/04
Telix Pharmaceuticals Limited completed the acquisition of IsoTherapeutics Group, LLC for $8.1 million.	09/04
Telix Pharmaceuticals - World First Use of Lightpoint's SENSEI Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	27/03
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	26/03
Telix Pharmaceuticals Limited Announces First Patient Dosed in Italian Named Patient ( Early Access) Program for TLX250-CDx Telix's Kidney Cancer Imaging Agent	25/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Telix Pharmaceuticals Limited

Aandelen

TLX

AU000000TLX2

Andere talen

Filters